SAROJA Statistics

Total Valuation

Saroja Pharma Industries India has a market cap or net worth of INR 233.99 million. The enterprise value is 288.12 million.

Market Cap	233.99M
Enterprise Value	288.12M

Important Dates

The next estimated earnings date is Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Saroja Pharma Industries India has 4.02 million shares outstanding. The number of shares has increased by 20.15% in one year.

Shares Outstanding	4.02M
Shares Change (YoY)	+20.15%
Shares Change (QoQ)	+36.18%
Owned by Insiders (%)	73.02%
Owned by Institutions (%)	n/a
Float	1.08M

Valuation Ratios

The trailing PE ratio is 23.37.

PE Ratio	23.37
Forward PE	n/a
PS Ratio	0.50
PB Ratio	1.62
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.28, with an EV/FCF ratio of -7.78.

EV / Earnings	32.80
EV / Sales	0.71
EV / EBITDA	11.28
EV / EBIT	11.71
EV / FCF	-7.78

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.39.

Current Ratio	1.89
Quick Ratio	1.78
Debt / Equity	0.39
Debt / EBITDA	2.25
Debt / FCF	-1.55
Interest Coverage	1.70

Financial Efficiency

Return on equity (ROE) is 8.90% and return on invested capital (ROIC) is 8.62%.

Return on Equity (ROE)	8.90%
Return on Assets (ROA)	6.42%
Return on Capital (ROIC)	8.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	13
Asset Turnover	1.70
Inventory Turnover	16.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.71%
50-Day Moving Average	51.21
200-Day Moving Average	51.36
Relative Strength Index (RSI)	54.52
Average Volume (20 Days)	21,360

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Saroja Pharma Industries India had revenue of INR 406.69 million and earned 8.78 million in profits. Earnings per share was 2.49.

Revenue	406.69M
Gross Profit	50.28M
Operating Income	24.60M
Pretax Income	12.07M
Net Income	8.78M
EBITDA	25.54M
EBIT	24.60M
Earnings Per Share (EPS)	2.49

Full Income Statement

Balance Sheet

The company has 3.22 million in cash and 57.35 million in debt, giving a net cash position of -54.13 million or -13.46 per share.

Cash & Cash Equivalents	3.22M
Total Debt	57.35M
Net Cash	-54.13M
Net Cash Per Share	-13.46
Equity (Book Value)	146.42M
Book Value Per Share	35.99
Working Capital	83.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.25 million and capital expenditures -47.29 million, giving a free cash flow of -37.04 million.

Operating Cash Flow	10.25M
Capital Expenditures	-47.29M
Free Cash Flow	-37.04M
FCF Per Share	-9.21

Full Cash Flow Statement

Margins

Gross margin is 12.36%, with operating and profit margins of 6.05% and 2.16%.

Gross Margin	12.36%
Operating Margin	6.05%
Pretax Margin	2.97%
Profit Margin	2.16%
EBITDA Margin	6.28%
EBIT Margin	6.05%
FCF Margin	-9.11%

Dividends & Yields

Saroja Pharma Industries India does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.15%
Shareholder Yield	-20.15%
Earnings Yield	4.28%
FCF Yield	-15.83%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Saroja Pharma Industries India has an Altman Z-Score of 3.89.

Altman Z-Score	3.89
Piotroski F-Score	n/a